News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Should Medicaid Tie Drug Prices To What Other Countries Pay?

hands holding scanner and pill bottle

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Launched November 2025, the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) program asks drug manufacturers to voluntarily reduce Medicaid’s prices to those paid by a group of seven peer nations including Canada, France, and the United Kingdom — a model known as Most Favored Nation pricing. States would then decide whether or not to accept the Most Favored Nation prices. In a perspective published on May 2 in The New England Journal of Medicine, Dr. Pragya Kakani, an assistant professor of population sciences at Weill Cornell Medicine, and her colleagues share the potential benefits and drawbacks of GENEROUS.

headshot of a woman

Dr. Pragya Kakani

Reverse Engineering Ketamine’s Effects May Lead to New Antidepressants

silhouette of a woman with her head in her hand

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

Dr. Conor Liston

Dr. Conor Liston. Credit: Julia Xanthos Liddy

While there are many effective treatments available for depression, not all patients respond to them. About one-third of patients must try multiple medications before eventually finding relief, and another third have treatment-resistant depression. An anesthetic called ketamine can provide immediate relief to some patients with treatment-resistant depression, but the effects are often short-lived. Ketamine also has serious side effects for some patients, including changes in heart rate or blood pressure, feelings of being disconnected from one’s thoughts or self and addiction.

Weill Cornell Centers DEI in Community—and Courage

Dr. Heidi Bender, Dr. Linnie Golightly and Fanesse Acquaye

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table.

That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. Dr. Golightly was joined by Dr. Heidi Bender, inaugural associate dean for faculty engagement and inclusion, and Fanesse Acquaye, executive director of the Office of Culture, Inclusion & Employee Experience for a fireside chat, as part of the institution’s eighth annual Diversity Week.

The nearly hour-long conversation explored Dr. Golightly’s legacy at Weill Cornell Medicine and her lifelong commitment to building institutions where everyone can feel they belong and every voice is heard. A 1983 graduate of Weill Cornell Medicine, Dr. Golightly spent close to 30 years of her professional career at the institution—joining the faculty in 1997 and then serving as associate dean of diversity and inclusion from 2016 until her departure in 2025.

She also discussed how she’s continuing the work in her current role, noting that the process continues by focusing on the opportunities ahead instead of looking back at the challenges already overcome. She stressed the importance of bridge-building—engaging skeptics and those unfamiliar with this work rather than retreating into like-minded circles.